You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
| Title |
A phase 1 trial of human telomerase reverse transcriptase (hTERT) vaccination combined with therapeutic strategies to control immune-suppressor mechanisms
|
|---|---|
| Published in |
Experimental Biology and Medicine, January 2024
|
| DOI | 10.3389/ebm.2024.10021 |
| Pubmed ID | |
| Authors |
Nahid Zareian, Oleg Eremin, Hardev Pandha, Richard Baird, Vineet Kwatra, Gabriel Funingana, Chandan Verma, Desmond Choy, Steven Hargreaves, Pejvak Moghimi, Adrian Shepherd, Dileep N. Lobo, Jennifer Eremin, Farzin Farzaneh, Shahram Kordasti, James Spicer |